Association of the CYP2B6 c.516G>T Polymorphism with High Blood Propofol Concentrations in Women from Northern Greece

被引：27
作者：
Mastrogianni, Orthodoxia [1 ]
Gbandi, Emma [2 ]
Orphanidis, Amvrosios [1 ]
Raikos, Nikolaos [1 ]
Goutziomitrou, Evangelia [3 ]
Kolibianakis, Efstratios M. [3 ]
Tarlatzis, Basil C. [3 ]
Goulas, Antonis [2 ]
机构：
[1] Aristotle Univ Thessaloniki, Sch Med, Dept Forens Med & Toxicol, Thessaloniki 54124, Greece
[2] Aristotle Univ Thessaloniki, Sch Med, Dept Pharmacol, Thessaloniki 54124, Greece
[3] Aristotle Univ Thessaloniki, Sch Med, Papageorgiou Gen Hosp, Dept Obstet & Gynecol 1,Unit Human Reprod, Thessaloniki 54124, Greece
来源：
DRUG METABOLISM AND PHARMACOKINETICS | 2014年 / 29卷 / 02期
关键词：
blood propofol; GC/MS; CYP2B6; gene polymorphism; HUMAN LIVER; UGT1A9; PHARMACOKINETICS; GLUCURONIDATION; METABOLITES; EXPRESSION; IMPACT; GENE;
D O I：
10.2133/dmpk.DMPK-13-NT-092
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Cytochrome P450 2B6 (CYP2B6) is responsible for the initial biotransformation of profol, an extensively metabolized intravenous anesthetic. In this study we examined the effect of the apparently functional CYP2B6 c.516G>T polymorphism on the distribution of propofol concentrations, quantified by GC/MS analysis following a single bolus dose, in the blood of 44 Greek women undergoing oocyte retrieval. Univariate analysis using age, height, weight and smoking status as covariates, as well as the Mann-Whitney non-parametric test, revealed a strong trend of association of the T allele with high propofol concentrations determined in whole blood, shortly after a single bolus dose. Propofol concentrations which were higher than one standard deviation of the mean were almost invariably associated with carriage of the T allele.
引用
收藏
页码：215 / 218
页数：4
相关论文
共 15 条
  • [1] Sex Difference in Formation of Propofol Metabolites: A Replication Study
    Choong, Eva
    Loryan, Irena
    Lindqvist, Marja
    Nordling, Asa
    el Bouazzaoui, Samira
    van Schaik, Ron H.
    Johansson, Inger
    Jakobsson, Jan
    Ingelman-Sundberg, Magnus
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 113 (02) : 126 - 131
  • [2] Cytochrome P-4502B6 is responsible for interindividual variability of propofol hydroxylation by human liver microsomes
    Court, MH
    Duan, SX
    Hesse, LM
    Venkatakrishnan, K
    Greenblatt, DJ
    [J]. ANESTHESIOLOGY, 2001, 94 (01) : 110 - 119
  • [3] Impact of CYP2B6 polymorphism on hepatic efavirenz metabolism in vitro
    Desta, Zeruesenay
    Saussele, Tanja
    Ward, Bryan
    Blievernicht, Julia
    Li, Lang
    Klein, Kathrin
    Flockhart, DavidA
    Zanger, Ulrich M.
    [J]. PHARMACOGENOMICS, 2007, 8 (06) : 547 - 558
  • [4] Propofol metabolites in man following propofol induction and maintenance
    Favetta, P
    Degoute, CS
    Perdrix, JP
    Dufresne, C
    Boulieu, R
    Guitton, J
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2002, 88 (05) : 653 - 658
  • [5] Identification of common polymorphisms in the promoter of the UGT1A9 gene: evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liver
    Girard, H
    Court, MH
    Bernard, O
    Fortier, LC
    Villeneuve, L
    Hao, Q
    Greenblatt, DJ
    von Moltke, LL
    Perussed, L
    Guillemette, C
    [J]. PHARMACOGENETICS, 2004, 14 (08): : 501 - 515
  • [6] The novel UGT1A9 intronic I399 polymorphism appears as a predictor of 7-ethyl-10-hydroxycamptothecin glucuronidation levels in the liver
    Girard, Hugo
    Villeneuve, Lyne
    Court, Michael H.
    Fortier, Louis-Charles
    Caron, Patrick
    Hao, Qin
    von Moltke, Lisa L.
    Greenblatt, David J.
    Guillemette, Chantal
    [J]. DRUG METABOLISM AND DISPOSITION, 2006, 34 (07) : 1220 - 1228
  • [7] Aberrant splicing caused by single nucleotide polymorphism c.516G> T [Q172H], a marker of CYP2B6*6, is responsible for decreased expression and activity of CYP2B6 in liver
    Hofmann, Marco H.
    Blievernicht, Julia K.
    Klein, Kathrin
    Saussele, Tanja
    Schaeffeler, Elke
    Schwab, Matthias
    Zanger, Ulrich M.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 325 (01) : 284 - 292
  • [8] An investigation of potential genetic determinants of propofol requirements and recovery from anaesthesia
    Iohom, G.
    Chonghaile, M. Ni
    O'Brien, J. K.
    Cunningham, A. J.
    Fitzgerald, D. F.
    Shields, D. C.
    [J]. EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2007, 24 (11) : 912 - 919
  • [9] Individual Differences in Pharmacokinetics and Pharmacodynamics of Anesthetic Agent Propofol with Regard to CYP2B6 and UGT1A9 Genotype and Patient Age
    Kansaku, Fumiyasu
    Kumai, Toshio
    Sasaki, Kuniharu
    Yokozuka, Makito
    Shimizu, Makiko
    Tateda, Tadashi
    Murayama, Norie
    Kobayashi, Shinichi
    Yamazaki, Hiroshi
    [J]. DRUG METABOLISM AND PHARMACOKINETICS, 2011, 26 (05) : 532 - 537
  • [10] Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver
    Lang, T
    Klein, K
    Fischer, J
    Nüssler, AK
    Neuhaus, P
    Hofmann, U
    Eichelbaum, M
    Schwab, M
    Zanger, UM
    [J]. PHARMACOGENETICS, 2001, 11 (05): : 399 - 415
12